Loading
PDBj
メニューPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

8HUG

F1 in complex with CRM1-Ran-RanBP1

8HUG の概要
エントリーDOI10.2210/pdb8hug/pdb
分子名称GTP-binding nuclear protein Ran, YRB1 isoform 1, CRM1 isoform 1, ... (10 entities in total)
機能のキーワードactive ran, complex, transport protein, inhibitor
由来する生物種Homo sapiens (human)
詳細
タンパク質・核酸の鎖数3
化学式量合計157690.77
構造登録者
Sun, Q.,Lei, Y. (登録日: 2022-12-23, 公開日: 2023-12-27, 最終更新日: 2024-07-10)
主引用文献Li, C.,Zhang, Q.,Huang, W.,Huang, L.,Long, Q.,Lei, Y.,Jia, D.,Yang, S.,Yang, Y.,Zhang, X.,Sun, Q.
Discovery of a Hidden Pocket beneath the NES Groove by Novel Noncovalent CRM1 Inhibitors.
J.Med.Chem., 66:17044-17058, 2023
Cited by
PubMed Abstract: Protein localization is frequently manipulated to favor tumor initiation and progression. In cancer cells, the nuclear export factor CRM1 is often overexpressed and aberrantly localizes many tumor suppressors via protein-protein interactions. Although targeting protein-protein interactions is usually challenging, covalent inhibitors, including the FDA-approved drug KPT-330 (selinexor), were successfully developed. The development of noncovalent CRM1 inhibitors remains scarce. Here, by shifting the side chain of two methionine residues and virtually screening against a large compound library, we successfully identified a series of noncovalent CRM1 inhibitors with a stable scaffold. Crystal structures of inhibitor-protein complexes revealed that one of the compounds, B28, utilized a deeply hidden protein interior cavity for binding. SAR analysis guided the development of several B28 derivatives with enhanced inhibition on nuclear export and growth of multiple cancer cell lines. This work may benefit the development of new CRM1-targeted therapies.
PubMed: 38105606
DOI: 10.1021/acs.jmedchem.3c01867
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.15 Å)
構造検証レポート
Validation report summary of 8hug
検証レポート(詳細版)ダウンロードをダウンロード

227111

件を2024-11-06に公開中

PDB statisticsPDBj update infoContact PDBjnumon